Weill Cornell Medicine researchers have received a two-year $500,000 grant from JDRF to evaluate an innovative approach to islet cell transplantation, an experimental treatment for difficult-to-control type 1 diabetes.
[Weill Cornell Medicine]
7992332
{7992332:CCCCCCCC}
apa
50
1
170330
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
